Three-Pronged attack on Tough-to-Treat sarcoma
NCT ID NCT04551430
Summary
This study is testing if combining three different cancer drugs works better than standard care for advanced soft tissue sarcoma that has spread. It will involve about 105 adults whose cancer has worsened after one or two prior treatments. The goal is to see if this combination can shrink tumors and control the cancer for longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center at Pennsylvania Hospital
Philadelphia, Pennsylvania, 19106, United States
-
Stanford University Medical Center
Stanford, California, 94305, United States
-
University of Colorado
Aurora, Colorado, 80045, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.